Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (Stat ...

InnovAge Holding Corp. (NASDAQ:INNV) Q2 2022 Results Conference Call February 9, 2022 5:00 PM ET Company Participants Ryan Kubota - Director, IR Patrick Blair - President and CEO Barb Gutierrez - CFO Dr. Melissa Welch - Chief Medical Officer Conference Call Participants Jason Cassorla - Citi Sarah James - Barclays Jeff Garro - Piper Sandler Lisa Gill - JP Morgan Jamie Perse - Goldman Sachs Gary Taylor - Cowen Matt Larew - William Blair Operator Good day and thank you for standing by. Welcome to the InnovAge ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (S ...

Financial Data and Key Metrics Changes - InnovAge reported first quarter revenue of approximately $173 million, an increase of nearly 13.5% compared to the previous fiscal year, driven by census growth and an increase in rates [7][27] - The company ended the quarter with a net income of $7.6 million, compared to a loss of $49.8 million in the first quarter of fiscal 2021, and up from $6.3 million in the fourth quarter of fiscal 2021 [32] - Adjusted EBITDA for the first quarter was $18.2 million, reflecting a 5.7% decrease quarter-over-quarter and a 21.2% decrease year-over-year [32][33] Business Line Data and Key Metrics Changes - The census increased to approximately 6,990 participants, representing a 7.2% increase compared to the first quarter of fiscal 2021 [6][25] - Member months for the first quarter were over 20,900, a 7.8% increase over the prior year [26] - Center-level contribution margin was $42.3 million for the first quarter, compared to $48 million in the previous quarter and $40.6 million in the first quarter of fiscal 2021 [29][30] Market Data and Key Metrics Changes - The company experienced a 65% growth in digital referrals compared to the previous quarter, indicating a successful digital marketing strategy [12][13] - External provider costs increased by 22.2% compared to the first quarter of fiscal 2021, attributed to higher per-participant costs in various care services [28] Company Strategy and Development Direction - InnovAge is on track to open three De Novo centers in fiscal 2023, with locations in Florida and Kentucky [8][9] - The company is actively pursuing acquisition opportunities in new markets and exploring joint venture opportunities to enhance strategic value [9][10] Management's Comments on Operating Environment and Future Outlook - Management reaffirmed guidance for fiscal year 2022, expecting ending census to be between 7,500 and 7,750 and total revenues in the range of $712 to $725 million [35][36] - The company is closely monitoring labor trends and has made wage adjustments to mitigate potential labor disruptions [14][15] Other Important Information - The company reported that 98% of employees and 89% of participants have been fully vaccinated against COVID-19 [10][11] - The regulatory environment remains positive, with potential funding increases for PACE providers through home and community-based services [16][17] Q&A Session Summary Question: Update on Sacramento corrective action plan - Management confirmed that a corrective action plan has been submitted to CMS, focusing on closing provider contracting gaps and improving staffing and training [42][43] Question: Impact of COVID on census growth - Management stated that COVID did not impact census growth projections, which were as expected for the quarter [49][50] Question: Factors impacting trends for the year - Management highlighted labor trends and potential COVID flare-ups as significant swing factors that could impact operations [51][52] Question: Timeline for Colorado audit outcomes - Management indicated that timelines for audit outcomes are uncertain and depend on CMS reviews [55][56] Question: Labor pressure impact on model - Management noted that labor pressures are primarily affecting recruitment rather than retention, with wage increases factored into guidance [81][82] Question: Digital marketing strategy contribution to growth - Management expressed optimism about the digital marketing strategy's potential but indicated that quantification of its impact will take more time [91][92]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 ( ...

EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES Commission File Number: 001-40159 InnovAge Holding Corp. (Exact name of registrant as specified in its charter) Delaware 81-0710819 (State or Othe ...

InnovAge Holding Corp. (NASDAQ:INNV) Q4 2021 Earnings Conference Call September 21, 2021 5:00 PM ET CorporateParticipants Ryan Kubota - Director of Investor Relations Maureen Hewitt - President and Chief Executive Officer Barb Gutierrez - Chief Financial Officer ConferenceCall Participants Vikram Kesavabhotla - Baird Jeff Garro - Piper Sandler Sarah James - Barclays Ralph Giacobbe - Citi Matt Larew - William Blair Jamie Perse - Goldman Sachs Operator Thank you for standing by and welcome to InnovAge’s Fisca ...

8950 E. Lowry Boulevard Denver, CO (Address of Principal Executive Offices) 80230 (Zip Code) (844) 803-8745 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-4 ...